Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years

Use of the generic versions of directly-acting antiviral drugs that are available in India to treat hepatitis C virus infection is not only cost effective but actually saves lifetime costs for treating infected patients in that country.
Source: ScienceDaily Headlines - Category: Science Source Type: news